Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer

Glenwood D. Goss, Gail E. Darling, Virginie Westeel, Kazuhiko Nakagawa, Bartomeu Massutí, Francesco Perrone, Sue-Anne McLachlan, Jin Hyoung Kang, Yi-Long Wu, Anne-Marie C. Dingemans, Rafal Dziadziuszko, Laurent Greillier, Morihito Okada, Clarisse Audigier-Valette, Shunichi Sugawara, Ernest Nadal, Annamaria Catino, Anne-Claire Toffart, Tetsuya Mitsudomi, Renaud Whittom, Manuel Domine, Nobuyuki Yamamoto, Olivier Molinier, Franck Morin, Penelope A. Bradbury, Martin R. Stockler, Keyue Ding, Christopher J. O'Callaghan

Open source

DOI: 10.1200/jco-25-01828
Published: 2026-03-01
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-01828,
  title = {Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer},
  author = {Glenwood D. Goss and Gail E. Darling and Virginie Westeel and Kazuhiko Nakagawa and Bartomeu Massutí and Francesco Perrone and Sue-Anne McLachlan and Jin Hyoung Kang and Yi-Long Wu and Anne-Marie C. Dingemans and Rafal Dziadziuszko and Laurent Greillier and Morihito Okada and Clarisse Audigier-Valette and Shunichi Sugawara and Ernest Nadal and Annamaria Catino and Anne-Claire Toffart and Tetsuya Mitsudomi and Renaud Whittom and Manuel Domine and Nobuyuki Yamamoto and Olivier Molinier and Franck Morin and Penelope A. Bradbury and Martin R. Stockler and Keyue Ding and Christopher J. O'Callaghan},
  year = {2026},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco-25-01828},
  url = {https://doi.org/10.1200/jco-25-01828}
}

RIS

TY  - JOUR
TI  - Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer
AU  - Glenwood D. Goss
AU  - Gail E. Darling
AU  - Virginie Westeel
AU  - Kazuhiko Nakagawa
AU  - Bartomeu Massutí
AU  - Francesco Perrone
AU  - Sue-Anne McLachlan
AU  - Jin Hyoung Kang
AU  - Yi-Long Wu
AU  - Anne-Marie C. Dingemans
AU  - Rafal Dziadziuszko
AU  - Laurent Greillier
AU  - Morihito Okada
AU  - Clarisse Audigier-Valette
AU  - Shunichi Sugawara
AU  - Ernest Nadal
AU  - Annamaria Catino
AU  - Anne-Claire Toffart
AU  - Tetsuya Mitsudomi
AU  - Renaud Whittom
AU  - Manuel Domine
AU  - Nobuyuki Yamamoto
AU  - Olivier Molinier
AU  - Franck Morin
AU  - Penelope A. Bradbury
AU  - Martin R. Stockler
AU  - Keyue Ding
AU  - Christopher J. O'Callaghan
PY  - 2026
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco-25-01828
UR  - https://doi.org/10.1200/jco-25-01828
ER  -

APA

Goss, G. D., Darling, G. E., Westeel, V., Nakagawa, K., Massutí, B., Perrone, F., McLachlan, S., Kang, J. H., Wu, Y., Dingemans, A. C., Dziadziuszko, R., Greillier, L., Okada, M., Audigier-Valette, C., Sugawara, S., Nadal, E., Catino, A., Toffart, A., Mitsudomi, T., Whittom, R., Domine, M., Yamamoto, N., Molinier, O., Morin, F., Bradbury, P. A., Stockler, M. R., Ding, K., & O'Callaghan, C. J. (2026). Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01828

Source records

crossref · retrieved 2026-09-27T10:26:29.177Z